Annual Operating Margin
15.97%
+43.29%+158.46%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual operating profit margin is 15.97%, with the most recent change of +43.29% (+158.46%) on December 31, 2023.
- During the last 3 years, PLX annual operating margin has risen by +11.66% (+270.53%).
- PLX annual operating margin is now at all-time high.
Performance
PLX Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
22.22%
+40.23%+223.38%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly operating profit margin is 22.22%, with the most recent change of +40.23% (+223.38%) on September 30, 2024.
- Over the past year, PLX quarterly operating margin has increased by +40.46% (+221.82%).
- PLX quarterly operating margin is now -86.49% below its all-time high of 164.52%, reached on December 31, 2013.
Performance
PLX Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
PLX Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +158.5% | +221.8% |
| 3 y3 years | +270.5% | +221.8% |
| 5 y5 years | +128.3% | +221.8% |
PLX Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.9% | -61.8% | +117.2% |
| 5 y | 5-year | at high | +129.9% | -61.8% | +115.6% |
| alltime | all time | at high | +100.2% | -86.5% | +100.0% |
Protalix BioTherapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 22.22%(-223.4%) |
| Jun 2024 | - | -18.01%(-86.1%) |
| Mar 2024 | - | -129.56%(+141.9%) |
| Dec 2023 | 15.97%(-158.5%) | -53.55%(+193.6%) |
| Sep 2023 | - | -18.24%(-131.3%) |
| Jun 2023 | - | 58.22%(-327.0%) |
| Mar 2023 | - | -25.65%(-11.4%) |
| Dec 2022 | -27.32%(-48.8%) | -28.95%(+31.4%) |
| Sep 2022 | - | -22.03%(-65.1%) |
| Jun 2022 | - | -63.11%(+442.6%) |
| Mar 2022 | - | -11.63%(-82.6%) |
| Dec 2021 | -53.36%(-1338.1%) | -66.74%(+326.7%) |
| Sep 2021 | - | -15.64%(-89.0%) |
| Jun 2021 | - | -142.62%(+335.7%) |
| Mar 2021 | - | -32.73%(-324.8%) |
| Dec 2020 | 4.31%(-122.0%) | 14.56%(-160.8%) |
| Sep 2020 | - | -23.93%(+17.2%) |
| Jun 2020 | - | -20.42%(-194.2%) |
| Mar 2020 | - | 21.68%(+75.0%) |
| Dec 2019 | -19.59%(-65.3%) | 12.39%(-214.3%) |
| Sep 2019 | - | -10.84%(-77.3%) |
| Jun 2019 | - | -47.68%(-10.1%) |
| Mar 2019 | - | -53.01%(+49.5%) |
| Dec 2018 | -56.39%(-65.6%) | -35.47%(+16.9%) |
| Sep 2018 | - | -30.33%(-78.2%) |
| Jun 2018 | - | -139.40%(+81.7%) |
| Mar 2018 | - | -76.72%(-65.5%) |
| Dec 2017 | -163.76%(-54.6%) | -222.58%(+115.7%) |
| Sep 2017 | - | -103.18%(-39.3%) |
| Jun 2017 | - | -169.94%(-22.9%) |
| Mar 2017 | - | -220.32%(-47.4%) |
| Dec 2016 | -360.51%(-33.5%) | -419.03%(+194.3%) |
| Sep 2016 | - | -142.36%(-74.6%) |
| Jun 2016 | - | -561.39%(-51.5%) |
| Mar 2016 | - | -1158.17%(+209.3%) |
| Dec 2015 | -542.39% | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -374.40%(-10.4%) |
| Jun 2015 | - | -417.96%(+31.4%) |
| Mar 2015 | - | -318.20%(-412.6%) |
| Dec 2014 | -810.64%(+2192.5%) | 101.78%(-160.8%) |
| Sep 2014 | - | -167.47%(-17.4%) |
| Jun 2014 | - | -202.79%(+131.5%) |
| Mar 2014 | - | -87.61%(-153.3%) |
| Dec 2013 | - | 164.52%(-197.9%) |
| Sep 2013 | - | -168.06%(-25.3%) |
| Jun 2013 | - | -225.00%(+101.6%) |
| Mar 2013 | - | -111.62%(-99.5%) |
| Dec 2012 | -35.36%(-97.1%) | -21.18 K%(>+9900.0%) |
| Sep 2012 | - | -103.15%(-370.8%) |
| Jun 2012 | - | 38.09%(-123.4%) |
| Mar 2012 | - | -162.69%(-87.3%) |
| Dec 2011 | -1230.83%(+361.8%) | -1285.63%(+31.5%) |
| Sep 2011 | - | -977.37%(-12.0%) |
| Jun 2011 | - | -1110.73%(+1222.8%) |
| Mar 2011 | - | -83.97%(-45.2%) |
| Dec 2010 | -266.51%(-96.8%) | -153.13%(+71.2%) |
| Sep 2010 | - | -89.45%(-89.4%) |
| Jun 2010 | - | -843.30%(-12.0%) |
| Mar 2010 | - | -958.68%(-75.2%) |
| Dec 2009 | -8239.43%(+113.5%) | -3869.85%(-99.9%) |
| Dec 2005 | -3859.33%(+586.6%) | - |
| Dec 2004 | -562.09%(+2348.1%) | - |
| Jun 2001 | - | -6.50 M%(-38.5%) |
| Mar 2001 | - | -10.58 M%(+579.6%) |
| Sep 2000 | - | -1.56 M%(-80.0%) |
| Jun 2000 | - | -7.78 M%(+14.1%) |
| Mar 2000 | - | -6.82 M%(>+9900.0%) |
| Dec 1999 | -22.96%(+57.2%) | -325.15%(+27.9%) |
| Sep 1999 | - | -254.15%(+1578.7%) |
| Jun 1999 | - | -15.14%(+351.9%) |
| Mar 1999 | - | -3.35% |
| Dec 1998 | -14.61% | - |
FAQ
- What is Protalix BioTherapeutics annual operating profit margin?
- What is the all time high annual operating margin for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual operating margin year-on-year change?
- What is Protalix BioTherapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly operating margin year-on-year change?
What is Protalix BioTherapeutics annual operating profit margin?
The current annual operating margin of PLX is 15.97%
What is the all time high annual operating margin for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual operating profit margin is 15.97%
What is Protalix BioTherapeutics annual operating margin year-on-year change?
Over the past year, PLX annual operating profit margin has changed by +43.29% (+158.46%)
What is Protalix BioTherapeutics quarterly operating profit margin?
The current quarterly operating margin of PLX is 22.22%
What is the all time high quarterly operating margin for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly operating profit margin is 164.52%
What is Protalix BioTherapeutics quarterly operating margin year-on-year change?
Over the past year, PLX quarterly operating profit margin has changed by +40.46% (+221.82%)